Broadfin Capital as of Dec. 31, 2011
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 36 positions in its portfolio as reported in the December 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alkermes (ALKS) | 8.0 | $17M | 1.0M | 17.36 | |
| Natus Medical | 7.4 | $16M | 1.7M | 9.43 | |
| Santarus | 7.0 | $15M | 4.6M | 3.31 | |
| Teva Pharmaceutical Industries (TEVA) | 5.6 | $12M | 300k | 40.36 | |
| Lannett Company | 5.0 | $11M | 2.4M | 4.42 | |
| Merit Medical Systems (MMSI) | 4.9 | $11M | 800k | 13.38 | |
| Sanofi-Aventis SA (SNY) | 4.4 | $9.5M | 260k | 36.54 | |
| AngioDynamics (ANGO) | 4.1 | $8.9M | 600k | 14.81 | |
| Alere | 4.0 | $8.7M | 376k | 23.09 | |
| Align Technology (ALGN) | 3.8 | $8.3M | 351k | 23.72 | |
| Rigel Pharmaceuticals | 3.8 | $8.2M | 1.0M | 7.89 | |
| Solta Medical | 3.6 | $7.9M | 2.5M | 3.14 | |
| Boston Scientific Corporation (BSX) | 3.6 | $7.8M | 1.5M | 5.34 | |
| St. Jude Medical | 3.5 | $7.7M | 223k | 34.30 | |
| Covidien | 3.4 | $7.4M | 165k | 45.01 | |
| AtriCure (ATRC) | 3.1 | $6.8M | 615k | 11.10 | |
| Medicis Pharmaceutical Corporation | 3.0 | $6.7M | 200k | 33.25 | |
| Amarin Corporation (AMRN) | 3.0 | $6.4M | 860k | 7.49 | |
| Anacor Pharmaceuticals In | 2.0 | $4.4M | 711k | 6.20 | |
| Antares Pharma | 1.9 | $4.2M | 1.9M | 2.20 | |
| Conceptus | 1.7 | $3.6M | 287k | 12.64 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $3.6M | 442k | 8.15 | |
| Progenics Pharmaceuticals | 1.6 | $3.6M | 418k | 8.54 | |
| Given Imaging | 1.3 | $2.8M | 163k | 17.43 | |
| Qlt | 1.2 | $2.7M | 369k | 7.20 | |
| Intellipharmaceuticsintl Inc C | 1.2 | $2.7M | 974k | 2.74 | |
| Medtronic | 1.2 | $2.5M | 66k | 38.24 | |
| Zimmer Holdings (ZBH) | 0.9 | $2.0M | 38k | 53.41 | |
| Stryker Corporation (SYK) | 0.9 | $1.9M | 38k | 49.71 | |
| HeartWare International | 0.8 | $1.8M | 26k | 69.00 | |
| Alphatec Holdings | 0.7 | $1.5M | 869k | 1.72 | |
| K-V Pharmaceutical Company | 0.6 | $1.2M | 872k | 1.40 | |
| Biolase Technology | 0.5 | $1.2M | 449k | 2.57 | |
| Ardea Biosciences | 0.4 | $878k | 52k | 16.81 | |
| NuVasive | 0.3 | $679k | 54k | 12.60 | |
| CAS Medical Systems | 0.0 | $76k | 43k | 1.76 |
